Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
7.78
+0.75 (10.67%)
At close: Feb 20, 2026, 4:00 PM EST
7.64
-0.14 (-1.80%)
After-hours: Feb 20, 2026, 7:54 PM EST
Ocular Therapeutix Market Cap
Ocular Therapeutix has a market cap or net worth of $1.69 billion as of February 20, 2026. Its market cap has increased by 37.76% in one year.
Market Cap
1.69B
Enterprise Value
1.03B
1-Year Change
37.76%
Ranking
Category
Stock Price
$7.78
Market Cap Chart
Since July 25, 2014, Ocular Therapeutix's market cap has increased from $270.50M to $1.69B, an increase of 526.12%. That is a compound annual growth rate of 17.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 1.53B | -40.83% |
| Dec 31, 2025 | 2.59B | 92.64% |
| Dec 31, 2024 | 1.34B | 279.05% |
| Dec 29, 2023 | 354.20M | 63.68% |
| Dec 30, 2022 | 216.40M | -59.48% |
| Dec 31, 2021 | 534.00M | -63.87% |
| Dec 31, 2020 | 1.48B | 678.20% |
| Dec 31, 2019 | 189.90M | 16.08% |
| Dec 31, 2018 | 163.60M | 24.89% |
| Dec 29, 2017 | 131.00M | -37.08% |
| Dec 30, 2016 | 208.20M | -10.18% |
| Dec 31, 2015 | 231.80M | -53.78% |
| Dec 31, 2014 | 501.50M | 85.40% |
| Jul 25, 2014 | 270.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oruka Therapeutics | 1.57B |
| Celldex Therapeutics | 1.56B |
| Enliven Therapeutics | 1.55B |
| Relay Therapeutics | 1.54B |
| AnaptysBio | 1.54B |
| uniQure | 1.52B |
| Monte Rosa Therapeutics | 1.52B |
| Biohaven | 1.51B |